Discover
ZBH
Zimmer Biomet Holdings, Inc.
84.17
300 x undefined
100 x undefined
bid
ask
-
1.92
2.23%
200 @ 04:00 PM
85.50 +1.33 (1.58%)
| Ytd | -6.39% | |
| 1y | -9.98% |
84.07
day range
87.20
79.12
52 week range
108.29
| Open | 86.70 | Prev Close | 86.09 | Low | 84.07 | High | 87.20 | Mkt Cap | 16.28B |
| Vol | 2.54M | Avg Vol | 2.39M | EPS | 3.86 | P/E | 21.81 | Forward P/E | 9.36 |
| Beta | 0.47 | Short Ratio | 5.49 | Inst. Own | 106.40% | Dividend | 0.96 | Div Yield | 1.12 |
| Ex Div Date | 06-25 | Earning | 04-28 | 50-d Avg | 86.12 | 200-d Avg | 91.90 | 1yr Est | 98.70 |
| Income Statement | |||
| Total Revenue | 2.09B | ||
| Revenues (USD) | 2.09B | ||
| Cost of Revenue | 576.20M | ||
| Gross Profit | 1.51B | ||
| Operating Expenses | 1.14B | ||
| Research and Development Expense | 103.40M | ||
| Selling, General and Administrative Expense | 849.90M | ||
| Operating Income | 373.20M | ||
| Interest Expense | 68.80M | ||
| Income Tax Expense | 63.00M | ||
| Net Income | 238.10M | ||
| Net Income Common Stock | 238.10M | ||
| Net Income Common Stock (USD) | 238.10M | ||
| Consolidated Income | 238.30M | ||
| Net Income to Non-Controlling Interests | 200.00K | ||
| Earnings per Basic Share | 1.22 | ||
| Earnings per Basic Share (USD) | 1.22 | ||
| Earnings per Diluted Share | 1.22 | ||
| Dividends per Basic Common Share | 0.24 | ||
| Earning Before Interest & Taxes (EBIT) | 369.90M | ||
| Earning Before Interest & Taxes (USD) | 369.90M | ||
| Weighted Average Shares | 195.00M | ||
| Weighted Average Shares Diluted | 195.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 424.20M | ||
| Cash and Equivalents (USD) | 424.20M | ||
| Trade and Non-Trade Receivables | 1.73B | ||
| Current Assets | 4.96B | ||
| Property, Plant & Equipment Net | 2.21B | ||
| Total Assets | 22.72B | ||
| Debt Current | 1.18B | ||
| Total Debt | 7.47B | ||
| Current Liabilities | 2.86B | ||
| Debt Non-Current | 6.30B | ||
| Total Liabilities | 10.04B | ||
| Accumulated Retained Earnings (Deficit) | 11.80B | ||
| Accumulated Other Comprehensive Income | -190.40M | ||
| Shareholders Equity | 12.67B | ||
| Shareholders Equity (USD) | 12.67B | ||
| Assets Non-Current | 17.76B | ||
| Total Debt (USD) | 7.47B | ||
| Goodwill and Intangible Assets | 14.48B | ||
| Inventory | 2.25B | ||
| Liabilities Non-Current | 7.18B | ||
| Trade and Non-Trade Payables | 361.20M | ||
| Tax Liabilities | 249.90M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 270.00M | ||
| Net Cash Flow from Financing | -369.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -167.70M | ||
| Capital Expenditure | -113.50M | ||
| Issuance (Purchase) of Equity Shares | -237.80M | ||
| Payment of Dividends & Other Cash Distributions | -46.90M | ||
| Net Cash Flow from Investing | -159.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -300.00K | ||
| Net Cash Flow from Operations | 359.40M | ||
| Effect of Exchange Rate Changes on Cash | 1.10M | ||
| Share Based Compensation | 24.20M | ||